ABCDEFGHIJKLMNOPQRSTUVWXY
1
Studies on Ivermectin Against COVID-19DateJournalParticipantsOutcome
2
Effects of Ivermectin-azithromycin-cholecalciferol combined therapy on COVID-19 infected patients: A proof of concept study2020Biomedical Research35Positive
3
Effectiveness of Ivermectin as add-on Therapy in COVID-19 ManagementJuly 8, 2020Preprint87Positive
4
Safety and Efficacy of the Combined Use of Ivermectin, Dexamethasone, Enoxaparin and Aspirin Against COVID-19Sept. 15, 2020Preprint167Positive
5
Study of the Efficacy and Safety of Topical Ivermectin + Iota-Carrageenan in the Prophylaxis against COVID-19 in Health PersonnelNov. 17, 2020Journal of Biomedical Research and Clinical Investigation229Positive
6
Use of Ivermectin as a Potential Chemoprophylaxis for COVID-19 in Egypt: A Randomised Clinical TrialFeb. 1, 2021Journal of Clinical and Diagnostic Research203 contacts to 52 index casesPositive
7
Efficacy of Ivermectin in COVID-19 Patients with Mild to Moderate DiseaseFeb. 5, 2021Preprint86Positive
8
A Comparative Study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID-19 PatientsFeb. 25, 2021Eurasian Journal of Medicine and Oncology116Positive
9
Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trialMay 2021International Journal of International Medical Research363Positive
10
Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19May 2021Journal of Medical Virology113Positive
11
Controlled Randomized Clinical Trial on Using Ivermectin with Doxycycline for Treating COVID-19 Patients in Baghdad, IraqMay 6, 2021Iraqi Journal of Medical Sciences140Positive
12
Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19June 15, 2021International Journal of Nanomedicine114Positive
13
Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort StudyAug. 13, 2021Cureus271Positive
14
Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, ArgentinaSept-Oct, 2021American Journal of Therapeutics234Positive
15
Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patientsFeb. 9, 2022Future Microbiology24Positive
16
Randomized trials – Ivermectin repurposing for COVID-19 treatment of outpatients with mild disease in primary health care centersJune 21, 2022Research, Society and Development254Positive
17
The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 – a double-blind, randomized placebo-controlled trialJuly 7, 2022International Journal of Infectious Diseases89Positive
18
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trialFeb. 1, 2021The Lancet24Mixed
19
Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trialApril 2021International Journal of Infectious Diseases3037Mixed
20
Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled studyJune 2, 2021Journal of Medical Virology164Mixed
21
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trialJuly 1, 2021The Lancet45Mixed
22
Ivermectin compared with placebo in the clinical evolution of Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trialMay 23, 2022Preprint66Mixed
23
Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trialAug. 26, 2022Trials72Mixed
24
Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled TrialFeb. 23, 2021Infectious Disease Reports106Not Supportive
25
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19March 4, 2021Journal of American Medical Association476Not Supportive
26
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patientsMay 4, 2021BMC Infectious Diseases66Not Supportive
27
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trialJuly 2, 2021BMC Infectious Diseases501Not Supportive
28
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and ComorbiditiesFeb. 18, 2022Journal of American Medical Association490Not Supportive
29
Effect of combined use of ivermectin and colchicine in COVID-19 patientsJune 22, 2022Egyptian Journal of Anesthesia135Not Supportive
30
Pharmacometric assessment of the in vivo antiviral activity of ivermectin in early symptomatic COVID-19July 19, 2022Preprint96Not Supportive
31
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19Aug. 18, 2022New England Journal of Medicine1323Not Supportive
32
Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trialOct 20, 2022Expert Review of Anti-infective TherapyunclearNot Supportive
33
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19Oct. 25, 2022Journal of American Medical Association1591Not Supportive
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100